Litigation for AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
✉ Email this page to a colleague
US Court Litigation for AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
| Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
|---|---|---|---|---|---|---|---|---|
| 8,163,723 | ⤷ Sign Up | ⤷ Sign Up | 2014-12-01 | 2017-05-17 | 28:2201 Declaratory Judgment | District Court, D. Delaware | None | ⤷ Sign Up |
| 8,163,723 | ⤷ Sign Up | ⤷ Sign Up | 2014-12-02 | 28:2201 Declaratory Judgment | District Court, D. Delaware | None | ⤷ Sign Up | |
| 8,163,723 | Meda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. | ⤷ Sign Up | 2015-09-08 | 2017-07-28 | 35:0145 | District Court, D. Delaware | None | ⤷ Sign Up |
| >Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |
Patent Trial and Appeal Board Cases for AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
| Patent | Petitioner | Status | Filing Date | Accorded Filing Date | Patent Owner | Trial Type | Trial Number | Decision Date | Inventor | Document Download |
|---|---|---|---|---|---|---|---|---|---|---|
| 8,163,723 | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | ⤷ Sign Up | 2020-01-31 | 01-31-2020 | Inter partes review | ⤷ Sign Up | 07-31-2020 | ⤷ Sign Up | ||
| 8,168,620 | Argentum Pharmaceuticals LLC | ⤷ Sign Up | 2017-02-02 | 02-02-2017 | Lulla et al | Inter partes review | ⤷ Sign Up | 08-21-2017 | ⤷ Sign Up | |
| 8,168,620 | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | ⤷ Sign Up | 2020-01-31 | 01-31-2020 | Inter partes review | ⤷ Sign Up | 07-31-2020 | ⤷ Sign Up | ||
| >Patent | >Petitioner | >Status | >Filing Date | >Accorded Filing Date | >Patent Owner | >Trial Type | >Trial Number | >Decision Date | >Inventor | >Document Download |
